TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from China Isotope & Radiation Corp. ( (HK:1763) ).
China Isotope & Radiation Corporation has signed an agreement with Brazil’s National Nuclear Energy Commission to supply cobalt-60 radioactive sources for irradiation purposes. This marks CIRC’s first export of self-produced cobalt-60 to the Latin American market, enhancing Brazil’s irradiation capacity and promoting the benefits of irradiation technology in various fields.
The most recent analyst rating on (HK:1763) stock is a Buy with a HK$25.00 price target. To see the full list of analyst forecasts on China Isotope & Radiation Corp. stock, see the HK:1763 Stock Forecast page.
More about China Isotope & Radiation Corp.
China Isotope & Radiation Corporation (CIRC) operates in the nuclear technology industry, focusing on the production and distribution of radioactive sources, particularly cobalt-60, for irradiation purposes. The company is expanding its market presence by engaging in international agreements to supply these products.
Average Trading Volume: 349,676
Technical Sentiment Signal: Buy
Current Market Cap: HK$7.48B
See more insights into 1763 stock on TipRanks’ Stock Analysis page.

